EcoDrugPlus

Ensembl ID : ENSNGAG00000019651
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSNGAG00000006663
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSNGAG00000013710
Gene Symbol: -
Cross references: -
53 Possible Orthologues:

Ensembl ID : ENSNGAG00000004867
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSNGAG00000011408
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSNGAG00000018207
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSNGAG00000001059
Gene Symbol: -
Cross references: -
147 Possible Orthologues:

Ensembl ID : ENSNGAG00000013595
Gene Symbol: -
Cross references: -
113 Possible Orthologues:

Ensembl ID : ENSNGAG00000012493
Gene Symbol: -
Cross references: -
379 Possible Orthologues:

Ensembl ID : ENSNGAG00000012284
Gene Symbol: -
Cross references: -
440 Possible Orthologues:

Ensembl ID : ENSNGAG00000022103
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSNGAG00000017099
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).